Citations

Showing 10 of 108104 citations.

Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I): An ACCRU trial.
Ruddy, Kathryn J. , Wilkinson, Mary, Woude, Amy C. Vander, Perdekamp, Maria T. Grosse, Dockter, Travis , Tan, Angelina D., Beutler, Andreas S. , Loprinzi, Charles L. , Le‐Rademacher, Jennifer , Lacouture, Mario E. , Onitilo, Adedayo A

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e22075-e22075

10.1200/jco.2018.36.15_suppl.e22075 Get It

Impact of body mass index (BMI) and weight change after treatment in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Secondary analysis of the ALTTO BIG 2-06 trial.
Martel, Samuel , Agbor‐Tarh, Dominique, Pondé, Noam , Gombos, Andrea , Paterson, Vicki, Hilbers, Florentine , Korde, Larissa A. , Manukyants, Anna, Maurer, Christian , Piccart, Martine , Moreno‐Aspitia, Alvaro , Desmedt, Christine , Lambertini, Matteo , Dueck, Amylou C. , Cosimo, Serena Di , Azambuja, Evandro de

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10067-10067

10.1200/jco.2018.36.15_suppl.10067 Get It

INPP5a expression as a prognostic marker in cutaneous squamous cell carcinoma (cSCC).
Liang, Helen J, DiCaudo, David J. , Schmidt, Jessica, Pittelkow, Mark R. , Sekulić, Aleksandar , Mangold, Aaron R. , Mangold, A R , Liang, Helen J

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e21567-e21567

10.1200/jco.2018.36.15_suppl.e21567 Get It

Is there a role for older-patient-specific cancer clinical trials? A pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715).
Jatoi, Aminah , Hurria, Arti , Muss, Hyman B. , Cohen, Harvey Jay, Citron, Marc L., Budman, Daniel R., Partridge, Ann, Lafky, Jacqueline M., Dao, Dyda , Zemla, Tyler , Freedman, Rachel A. , Shulman, Lawrence N. , McMurray, Ryan P. , Carey, Lisa A. , Le‐Rademacher, Jennifer

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10034-10034

10.1200/jco.2018.36.15_suppl.10034 Get It

Scrambler therapy for established chemotherapy-induced neuropathy: A randomized phase II trial.
Loprinzi, Charles L. , Majithia, Neil , Bendel, Markus A. , Beutler, Andreas S. , Strick, D. M., Tilburt, Jon C. , Le‐Rademacher, Jennifer , McMurray, Ryan P. , Lachance, Daniel Honore , Cheville, Andrea , Smith, Thomas J.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10016-10016

10.1200/jco.2018.36.15_suppl.10016 Get It

ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in merkel cell carcinoma patients with clinically detected lymph node metastases; NCT03271372.
Chandra, Sunandana , Dakhil, Sumia, Fecher, Leslie A. , Gooley, Ted , Hibbert, Reina, Kelly, Ciara M. , Kiriluk, Samantha M., Nghiem, Paul , Nguyen, Vivian , Pelz, Nichole Real, Poisson, Aubrey A., Price, Katharine A. , Sondak, Vernon K. , Thompson, John A. , Bhatia, Shailender , Brohl, Andrew S. , Brownell, Isaac , Ernstoff, Marc S. , Hanna, Glenn J. , Tykodi, Scott S.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS9605-TPS9605

10.1200/jco.2018.36.15_suppl.tps9605 Get It

Sex differences in tolerability to Anti-PD1 therapy: Are we all equal?
Duma, Narjust , Yadav, Siddhartha , Vera-Aguilera, Jesús, Kottschade, Lisa A. , Adjei, Alex A. , Dronca, Roxana , Yadav, Siddhartha , Paludo, Jonas , Enninga, Elizabeth Ann L. , Dong, Haidong

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9547-9547

10.1200/jco.2018.36.15_suppl.9547 Get It

Dose expansion cohort of a phase I trial of M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC).
Plummer, Elizabeth Ruth, Cook, Natalie , Melear, Jason M., Redfern, Charles H., Chung, Ki Y. , Haddad, Tufia C. , Goddemeier, Thomas, Arkenau, Hendrik‐Tobias , Spira, Alexander I. , Shapiro, Geoffrey I. , Ramalingam, Suresh S. , Wesolowski, Robert , Falk, Martin H., Dean, Emma

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e21048-e21048

10.1200/jco.2018.36.15_suppl.e21048 Get It

The prognostic significance of ATRX in pulmonary carcinoid tumors.
Terra, Simone , Molina, Julian R. , Roden, Anja C. , Xie, Hao , Boland, Jennifer M. , Mansfield, Aaron S.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e20543-e20543

10.1200/jco.2018.36.15_suppl.e20543 Get It

Maintenance (MT) treatment (Tx) after lenalidomide, bortezomib, and dexamethasone (RVD) induction and stem cell transplant (SCT) in high-risk (HR) patients (pts) with newly diagnosed multiple myeloma (NDMM): A real-world analysis.
Parikh, Kejal , Ung, Brian , Ni, Quanhong, Agarwal, Amit , Fonseca, Rafaël

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e20041-e20041

10.1200/jco.2018.36.15_suppl.e20041 Get It